Global 3D-Printed Medicinal Tablet 麻豆原创 Research Report 2024

Publication ID:

PB507248824

Publication Date:

July 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global 3D-Printed Medicinal Tablet market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for 3D-Printed Medicinal Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D-Printed Medicinal Tablet.
Report Scope
The 3D-Printed Medicinal Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 3D-Printed Medicinal Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D-Printed Medicinal Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
FabRx
Extend Biosciences
Triastek, Inc.
Merck
Osmotica Pharmaceuticals
Aprecia
GlaxoSmithKline
Affinity Therapeutics
Hewlett Packard Caribe
Bioduro
Cycle Pharmaceuticals
Segment by Type
Fused Deposition Modelling
Inkjet Printing
Zip Dose
Vat Photopolymerization
Segment by Application
Hospitals and Clinics
Research Laboratories
Pharmaceutical
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 3D-Printed Medicinal Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 3D-Printed Medicinal Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 3D-Printed Medicinal Tablet 麻豆原创 Overview
1.1 Product Overview and Scope of 3D-Printed Medicinal Tablet
1.2 3D-Printed Medicinal Tablet Segment by Type
1.2.1 Global 3D-Printed Medicinal Tablet 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Fused Deposition Modelling
1.2.3 Inkjet Printing
1.2.4 Zip Dose
1.2.5 Vat Photopolymerization
1.3 3D-Printed Medicinal Tablet Segment by Application
1.3.1 Global 3D-Printed Medicinal Tablet 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Research Laboratories
1.3.4 Pharmaceutical
1.3.5 Others
1.4 Global 3D-Printed Medicinal Tablet 麻豆原创 Size Estimates and Forecasts
1.4.1 Global 3D-Printed Medicinal Tablet Revenue 2019-2030
1.4.2 Global 3D-Printed Medicinal Tablet Sales 2019-2030
1.4.3 Global 3D-Printed Medicinal Tablet 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 3D-Printed Medicinal Tablet 麻豆原创 Competition by Manufacturers
2.1 Global 3D-Printed Medicinal Tablet Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global 3D-Printed Medicinal Tablet Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global 3D-Printed Medicinal Tablet Average Price by Manufacturers (2019-2024)
2.4 Global 3D-Printed Medicinal Tablet Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 3D-Printed Medicinal Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 3D-Printed Medicinal Tablet, Product Type & Application
2.7 3D-Printed Medicinal Tablet 麻豆原创 Competitive Situation and Trends
2.7.1 3D-Printed Medicinal Tablet 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 3D-Printed Medicinal Tablet Players 麻豆原创 Share by Revenue
2.7.3 Global 3D-Printed Medicinal Tablet 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 3D-Printed Medicinal Tablet Retrospective 麻豆原创 Scenario by Region
3.1 Global 3D-Printed Medicinal Tablet 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global 3D-Printed Medicinal Tablet Global 3D-Printed Medicinal Tablet Sales by Region: 2019-2030
3.2.1 Global 3D-Printed Medicinal Tablet Sales by Region: 2019-2024
3.2.2 Global 3D-Printed Medicinal Tablet Sales by Region: 2025-2030
3.3 Global 3D-Printed Medicinal Tablet Global 3D-Printed Medicinal Tablet Revenue by Region: 2019-2030
3.3.1 Global 3D-Printed Medicinal Tablet Revenue by Region: 2019-2024
3.3.2 Global 3D-Printed Medicinal Tablet Revenue by Region: 2025-2030
3.4 North America 3D-Printed Medicinal Tablet 麻豆原创 Facts & Figures by Country
3.4.1 North America 3D-Printed Medicinal Tablet 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America 3D-Printed Medicinal Tablet Sales by Country (2019-2030)
3.4.3 North America 3D-Printed Medicinal Tablet Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe 3D-Printed Medicinal Tablet 麻豆原创 Facts & Figures by Country
3.5.1 Europe 3D-Printed Medicinal Tablet 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe 3D-Printed Medicinal Tablet Sales by Country (2019-2030)
3.5.3 Europe 3D-Printed Medicinal Tablet Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 3D-Printed Medicinal Tablet 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific 3D-Printed Medicinal Tablet 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific 3D-Printed Medicinal Tablet Sales by Country (2019-2030)
3.6.3 Asia Pacific 3D-Printed Medicinal Tablet Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 3D-Printed Medicinal Tablet 麻豆原创 Facts & Figures by Country
3.7.1 Latin America 3D-Printed Medicinal Tablet 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America 3D-Printed Medicinal Tablet Sales by Country (2019-2030)
3.7.3 Latin America 3D-Printed Medicinal Tablet Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 3D-Printed Medicinal Tablet 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa 3D-Printed Medicinal Tablet 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa 3D-Printed Medicinal Tablet Sales by Country (2019-2030)
3.8.3 Middle East and Africa 3D-Printed Medicinal Tablet Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 3D-Printed Medicinal Tablet Sales by Type (2019-2030)
4.1.1 Global 3D-Printed Medicinal Tablet Sales by Type (2019-2024)
4.1.2 Global 3D-Printed Medicinal Tablet Sales by Type (2025-2030)
4.1.3 Global 3D-Printed Medicinal Tablet Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global 3D-Printed Medicinal Tablet Revenue by Type (2019-2030)
4.2.1 Global 3D-Printed Medicinal Tablet Revenue by Type (2019-2024)
4.2.2 Global 3D-Printed Medicinal Tablet Revenue by Type (2025-2030)
4.2.3 Global 3D-Printed Medicinal Tablet Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global 3D-Printed Medicinal Tablet Price by Type (2019-2030)
5 Segment by Application
5.1 Global 3D-Printed Medicinal Tablet Sales by Application (2019-2030)
5.1.1 Global 3D-Printed Medicinal Tablet Sales by Application (2019-2024)
5.1.2 Global 3D-Printed Medicinal Tablet Sales by Application (2025-2030)
5.1.3 Global 3D-Printed Medicinal Tablet Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global 3D-Printed Medicinal Tablet Revenue by Application (2019-2030)
5.2.1 Global 3D-Printed Medicinal Tablet Revenue by Application (2019-2024)
5.2.2 Global 3D-Printed Medicinal Tablet Revenue by Application (2025-2030)
5.2.3 Global 3D-Printed Medicinal Tablet Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global 3D-Printed Medicinal Tablet Price by Application (2019-2030)
6 Key Companies Profiled
6.1 FabRx
6.1.1 FabRx Corporation Information
6.1.2 FabRx Description and Business Overview
6.1.3 FabRx 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.1.4 FabRx 3D-Printed Medicinal Tablet Product Portfolio
6.1.5 FabRx Recent Developments/Updates
6.2 Extend Biosciences
6.2.1 Extend Biosciences Corporation Information
6.2.2 Extend Biosciences Description and Business Overview
6.2.3 Extend Biosciences 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Extend Biosciences 3D-Printed Medicinal Tablet Product Portfolio
6.2.5 Extend Biosciences Recent Developments/Updates
6.3 Triastek, Inc.
6.3.1 Triastek, Inc. Corporation Information
6.3.2 Triastek, Inc. Description and Business Overview
6.3.3 Triastek, Inc. 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Triastek, Inc. 3D-Printed Medicinal Tablet Product Portfolio
6.3.5 Triastek, Inc. Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck 3D-Printed Medicinal Tablet Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Osmotica Pharmaceuticals
6.5.1 Osmotica Pharmaceuticals Corporation Information
6.5.2 Osmotica Pharmaceuticals Description and Business Overview
6.5.3 Osmotica Pharmaceuticals 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Osmotica Pharmaceuticals 3D-Printed Medicinal Tablet Product Portfolio
6.5.5 Osmotica Pharmaceuticals Recent Developments/Updates
6.6 Aprecia
6.6.1 Aprecia Corporation Information
6.6.2 Aprecia Description and Business Overview
6.6.3 Aprecia 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aprecia 3D-Printed Medicinal Tablet Product Portfolio
6.6.5 Aprecia Recent Developments/Updates
6.7 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline 3D-Printed Medicinal Tablet Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Affinity Therapeutics
6.8.1 Affinity Therapeutics Corporation Information
6.8.2 Affinity Therapeutics Description and Business Overview
6.8.3 Affinity Therapeutics 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Affinity Therapeutics 3D-Printed Medicinal Tablet Product Portfolio
6.8.5 Affinity Therapeutics Recent Developments/Updates
6.9 Hewlett Packard Caribe
6.9.1 Hewlett Packard Caribe Corporation Information
6.9.2 Hewlett Packard Caribe Description and Business Overview
6.9.3 Hewlett Packard Caribe 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hewlett Packard Caribe 3D-Printed Medicinal Tablet Product Portfolio
6.9.5 Hewlett Packard Caribe Recent Developments/Updates
6.10 Bioduro
6.10.1 Bioduro Corporation Information
6.10.2 Bioduro Description and Business Overview
6.10.3 Bioduro 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bioduro 3D-Printed Medicinal Tablet Product Portfolio
6.10.5 Bioduro Recent Developments/Updates
6.11 Cycle Pharmaceuticals
6.11.1 Cycle Pharmaceuticals Corporation Information
6.11.2 Cycle Pharmaceuticals 3D-Printed Medicinal Tablet Description and Business Overview
6.11.3 Cycle Pharmaceuticals 3D-Printed Medicinal Tablet Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cycle Pharmaceuticals 3D-Printed Medicinal Tablet Product Portfolio
6.11.5 Cycle Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 3D-Printed Medicinal Tablet Industry Chain Analysis
7.2 3D-Printed Medicinal Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 3D-Printed Medicinal Tablet Production Mode & Process
7.4 3D-Printed Medicinal Tablet Sales and 麻豆原创ing
7.4.1 3D-Printed Medicinal Tablet Sales Channels
7.4.2 3D-Printed Medicinal Tablet Distributors
7.5 3D-Printed Medicinal Tablet Customers
8 3D-Printed Medicinal Tablet 麻豆原创 Dynamics
8.1 3D-Printed Medicinal Tablet Industry Trends
8.2 3D-Printed Medicinal Tablet 麻豆原创 Drivers
8.3 3D-Printed Medicinal Tablet 麻豆原创 Challenges
8.4 3D-Printed Medicinal Tablet 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

FabRx
Extend Biosciences
Triastek, Inc.
Merck
Osmotica Pharmaceuticals
Aprecia
GlaxoSmithKline
Affinity Therapeutics
Hewlett Packard Caribe
Bioduro
Cycle Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.